Advertisement Vision-Sciences names new executive vice-president and CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Vision-Sciences names new executive vice-president and CFO

Vision-Sciences, a developer and marketer of endoscopic products, has appointed Katherine Wolf as its new executive vice-president of corporate development and CFO, effective immediately.

In this role Ms Wolf will be responsible for all of Vision-Sciences’s financial operations and business development activities.

Before joining Vision-Sciences, Ms Wolf was a managing director at HSBC in its investment banking division where she was a founding member of the firm’s health care group. Ms Wolf holds an MBA from Harvard Business School and a BA from Williams College.

Ron Hadani, president and CEO of Vision-Sciences, said: “Katherine has tremendous experience in healthcare investment banking and finance, which will be invaluable to Vision-Sciences as we continue to expand the applications for our technologies.”